Toward a validated European instrument to measure the socioeconomic impact of cancer
What's new? The Financial Index of Toxicity (FIT) evaluates patients' experiences of financial strain after cancer diagnosis. Originally developed in Canada for head and neck cancer patients, the applicability of FIT to other populations remains uncertain. This study assessed the validity of FIT in Europe using patient‐level data from six countries and
Jasper Ubels +6 more
wiley +1 more source
A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy. [PDF]
Dong S +7 more
europepmc +1 more source
Traditionally, clinical outcomes measuring how a patient feels, functions, or survives are preferred endpoints in clinical trials; however, some may take a long time to manifest in slowly developing diseases. Biomarkers, if properly validated, can serve as surrogate endpoints, acting as substitutes for clinical outcomes.
Renske Johanna Grupstra +4 more
wiley +1 more source
Validity of EQ-5D-5L breathing and cognition bolt-ons in non-hospitalized patients after COVID-19. [PDF]
Stavem K, Garratt AM.
europepmc +1 more source
Does Digital Make a Difference? Willingness‐to‐Pay for Digital Versus Offline Weight Loss in Germany
ABSTRACT Background Germany introduced both digital health applications (DiGA) and an “offline” structured disease management program (DMP) for obesity within statutory health insurance. Given limited resources and ongoing reimbursement decisions, evidence on how individuals with obesity assessed the value of intervention delivery in terms of their ...
Kevin Helms +3 more
wiley +1 more source
Derivation of a South African tariff for the EQ-5D-5L using a personal utility function approach. [PDF]
Moolla A +5 more
europepmc +1 more source
ABSTRACT Objective To estimate utilization and economic effects of a language‐concordant, pharmacist‐integrated care‐management program and examine equity by language and insurance. Study Setting and Design We conducted a retrospective cohort study emulating a target trial across four Phoenix safety‐net clinics (March 2022–September 2023) using inverse
Sasha R. Sioni +4 more
wiley +1 more source
Identifying and developing EQ-5D-5L bolt-on items for Chinese chronic obstructive pulmonary disease patients. [PDF]
Feng J +9 more
europepmc +1 more source
The molecular mechanisms of RORA targeting PRNP activate oxidative injury‐induced cellular senescence and apoptosis of lens epithelial cells. Current research confirms that the transcription factor RORA targets PRNP, exacerbating cellular senescence and apoptosis of LECs (Figure 7).
Yue Zou +11 more
wiley +1 more source
Biases in the measurement of health-related quality of life in the EQ-5D-5L among those with serious physical traumatic injuries: the ADVANCE cohort study. [PDF]
Dyball D +8 more
europepmc +1 more source

